Page last updated: 2024-12-07

1-pyrrolidinebutyramide-2-methyl-alpha,alpha-diphenyl

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

The chemical name 1-pyrrolidinebutyramide-2-methyl-alpha,alpha-diphenyl refers to a specific organic compound. However, this name is not standard and isn't easily searchable in chemical databases.

Let's break down the name to understand what it likely describes:

* **1-pyrrolidinebutyramide:** This part suggests the compound is an amide derivative, meaning it has a carbonyl group (C=O) connected to a nitrogen atom. The pyrrolidine suggests a five-membered ring containing a nitrogen atom is attached to the amide nitrogen. Butyramide indicates a four-carbon chain connected to the carbonyl group.
* **2-methyl:** This implies a methyl group (CH3) is attached to the second carbon atom in the four-carbon chain.
* **alpha,alpha-diphenyl:** This refers to two phenyl groups (benzene rings) attached to the alpha carbon, which is the carbon directly attached to the carbonyl group.

**Based on this information, the compound likely has the following structure:**

[Insert image of the possible structure of the compound]

**Importance for Research:**

While it's impossible to state definitively why this specific compound is important for research without further context, we can speculate:

* **Potential Drug Candidate:** The combination of a heterocyclic ring (pyrrolidine) and an amide group is common in pharmaceuticals. This compound may be a potential drug candidate with activity against specific biological targets.
* **Building Block for Synthesis:** The compound could be a valuable intermediate in the synthesis of other more complex molecules with medicinal or material science applications.
* **Investigating Structure-Activity Relationships:** Researchers might use this compound to study the effects of different functional groups and molecular structures on biological activity or chemical properties.

**To find out the specific research relevance of this compound, you would need additional information, such as:**

* **The research group or project studying it.**
* **The specific biological target or chemical property being investigated.**
* **Any published research papers or patents mentioning this compound.**

You can use chemical databases like PubChem or SciFinder to search for the compound using its likely structure or by looking for similar compounds with known research relevance.

1-pyrrolidinebutyramide-2-methyl-alpha,alpha-diphenyl: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID96466
CHEMBL ID1894675
SCHEMBL ID11712873
MeSH IDM0147132

Synonyms (13)

Synonym
nsc-75575
mls002693951 ,
37918-25-5
nsc75575
NCIOPEN2_008511
smr001559889
HMS3094C03
nsc 75575
1-pyrrolidinebutyramide-2-methyl-alpha,alpha-diphenyl
1-pyrrolidinebutanamide, 2-methyl-alpha,alpha-diphenyl-
1-pbmdp
SCHEMBL11712873
CHEMBL1894675
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.34 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]